We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$629M
AUM Growth
+$43M
(+7.3%)
Cap. Flow
-$9.68M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
200
New
10
Increased
51
Reduced
94
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.07M |
| 2 |
ProShares UltraShort Dow 30
DXD
|
+$536K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$511K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$298K |
| 5 |
American Tower
AMT
|
+$228K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$3.65M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.43M |
| 3 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$639K |
| 4 |
ProShares UltraShort S&P500
SDS
|
+$590K |
| 5 |
Apple
AAPL
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Financials | 12.6% |
| 3 | Communication Services | 9.36% |
| 4 | Healthcare | 8.82% |
| 5 | Industrials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard Growth ETF
VUG
$216B
| $1.97M | 0.31% |
65,010
+2,076
| +3% | +$60K |
|
77
Medtronic
MDT
$107B
| $1.96M | 0.31% |
17,311
+845
| +5% | +$92.7K |
|
78
Salesforce
CRM
$134B
| $1.92M | 0.31% |
11,823
+499
| +4% | +$78.2K |
|
79
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
| $1.79M | 0.28% |
153,864
+984
| +0.6% | +$10.8K |
|
80
iShares Core S&P Small-Cap ETF
IJR
$109B
| $1.72M | 0.27% |
20,500
-130
| -0.6% | -$10.5K |
|
81
iShares MSCI Emerging Markets ETF
EEM
$28B
| $1.69M | 0.27% |
37,609
+247
| +0.7% | +$10.6K |
|
82
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $1.68M | 0.27% |
83,589
+1,248
| +2% | +$24.2K |
|
83
Home Depot
HD
$332B
| $1.66M | 0.26% |
7,578
+116
| +2% | +$26.3K |
|
|
FOCS
84
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $1.63M | 0.26% |
55,187
-25,000
| -31% | -$639K |
|
85
Phillips 66
PSX
$82.9B
| $1.63M | 0.26% |
14,588
-663
| -4% | -$74.5K |
|
86
iShares US Real Estate ETF
IYR
$4.59B
| $1.59M | 0.25% |
17,079
-40
| -0.2% | -$3.71K |
|
87
Cummins
CMI
$91.7B
| $1.54M | 0.24% |
8,611
-564
| -6% | -$99.3K |
|
88
Vanguard Mid-Cap ETF
VO
$106B
| $1.5M | 0.24% |
33,768
+1,916
| +6% | +$82.3K |
|
89
Douglas Emmett
DEI
$2.06B
| $1.4M | 0.22% |
31,917
-658
| -2% | -$28.5K |
|
90
Vanguard Total World Stock ETF
VT
$76.3B
| $1.4M | 0.22% |
17,259
+165
| +1% | +$12.8K |
|
91
NVIDIA
NVDA
$5.01T
| $1.35M | 0.22% |
230,280
+14,600
| +7% | +$75.9K |
|
92
Analog Devices
ADI
$181B
| $1.34M | 0.21% |
11,291
-125
| -1% | -$14.1K |
|
93
Caterpillar
CAT
$409B
| $1.33M | 0.21% |
9,020
-90
| -1% | -$12.6K |
|
94
Essential Utilities
WTRG
$11.2B
| $1.32M | 0.21% |
28,127
-458
| -2% | -$20.6K |
|
95
Arrowhead Research
ARWR
$12.1B
| $1.27M | 0.2% |
20,100
| – | – |
|
96
Schwab US Dividend Equity ETF
SCHD
$102B
| $1.26M | 0.2% |
65,427
+2,052
| +3% | +$38.4K |
|
97
Palo Alto Networks
PANW
$264B
| $1.22M | 0.19% |
31,746
-90
| -0.3% | -$3.4K |
|
98
Netflix
NFLX
$292B
| $1.2M | 0.19% |
37,200
-1,990
| -5% | -$59K |
|
99
Vanguard Total Stock Market ETF
VTI
$654B
| $1.17M | 0.19% |
7,175
+98
| +1% | +$15.4K |
|
100
GE Aerospace
GE
$367B
| $1.17M | 0.19% |
21,058
-2,457
| -10% | -$127K |
|
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q4 2019 Portfolio in Review
As of Q4 2019, HoyleCohen held 200 positions worth $629M, up 7.3% from $586M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HoyleCohen's Q4 2019 filing shows 10 new, 51 increased, 94 reduced and 5 closed positions. Its largest new stake was ProShares UltraShort Dow 30: 4,400 shares worth $496K. The largest sale was Celgene Corp, an estimated $3.65M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- HoyleCohen's largest Q4 2019 buy was ProShares UltraShort Dow 30: 4,400 shares worth $496K.
- HoyleCohen added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.07M increase.
- HoyleCohen's biggest Q4 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.43M.
- HoyleCohen fully exited Celgene Corp in Q4 2019, selling an estimated $3.65M.
- HoyleCohen's ten largest holdings make up 31% of its $629M portfolio in Q4 2019.
- HoyleCohen opened 10 new positions and closed 5 in Q4 2019.
- HoyleCohen's portfolio value rose 7.3% quarter-over-quarter to $629M.
Based on HoyleCohen's 13F filing for Q4 2019, filed 10 Feb 2020.